| The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis TD Henry, BH Annex, GR McKendall, MA Azrin, JJ Lopez, FJ Giordano, ... Circulation 107 (10), 1359-1365, 2003 | 1362 | 2003 |
| Aging, progenitor cell exhaustion, and atherosclerosis FM Rauscher, PJ Goldschmidt-Clermont, BH Davis, T Wang, D Gregg, ... Circulation 108 (4), 457-463, 2003 | 939 | 2003 |
| Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial M Simons, BH Annex, RJ Laham, N Kleiman, T Henry, H Dauerman, ... Circulation 105 (7), 788-793, 2002 | 844 | 2002 |
| Atherosclerotic vascular disease conference: writing group III: pathophysiology DP Faxon, V Fuster, P Libby, JA Beckman, WR Hiatt, RW Thompson, ... Circulation 109 (21), 2617-2625, 2004 | 841* | 2004 |
| A novel protective effect of erythropoietin in the infarcted heart CJ Parsa, A Matsumoto, J Kim, RU Riel, LS Pascal, GB Walton, ... The Journal of clinical investigation 112 (7), 999-1007, 2003 | 786 | 2003 |
| Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of … S Rajagopalan, ER Mohler III, RJ Lederman, FO Mendelsohn, ... Circulation 108 (16), 1933-1938, 2003 | 726 | 2003 |
| Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial RJ Lederman, FO Mendelsohn, RD Anderson, JF Saucedo, AN Tenaglia, ... The Lancet 359 (9323), 2053-2058, 2002 | 691 | 2002 |
| Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF A Rivard, M Silver, D Chen, M Kearney, M Magner, B Annex, K Peters, ... The American journal of pathology 154 (2), 355-363, 1999 | 610 | 1999 |
| Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population MR Nehler, S Duval, L Diao, BH Annex, WR Hiatt, K Rogers, A Zakharyan, ... Journal of vascular surgery 60 (3), 686-695. e2, 2014 | 525 | 2014 |
| Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes BH Annex, SM Denning, KM Channon, MH Sketch Jr, RS Stack, ... Circulation 91 (3), 619-622, 1995 | 426 | 1995 |
| A target‐mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans SM Eppler, DL Combs, TD Henry, JJ Lopez, SG Ellis, JH Yi, BH Annex, ... Clinical Pharmacology & Therapeutics 72 (1), 20-32, 2002 | 339 | 2002 |
| Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients … RJ Powell, M Simons, FO Mendelsohn, G Daniel, TD Henry, M Koga, ... Circulation 118 (1), 58-65, 2008 | 330 | 2008 |
| Therapeutic angiogenesis for critical limb ischaemia BH Annex Nature Reviews Cardiology 10 (7), 387-396, 2013 | 324 | 2013 |
| Impaired Collateral Vessel Development Associated With Reduced Expression of Vascular Endothelial Growth Factor in ApoE−/− Mice T Couffinhal, M Silver, M Kearney, A Sullivan, B Witzenbichler, M Magner, ... Circulation 99 (24), 3188-3198, 1999 | 316 | 1999 |
| A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use FTH Wu, MO Stefanini, FM Gabhann, CD Kontos, BH Annex, AS Popel Journal of cellular and molecular medicine 14 (3), 528-552, 2010 | 270 | 2010 |
| Voluntary running induces fiber type-specific angiogenesis in mouse skeletal muscle RE Waters, S Rotevatn, P Li, BH Annex, Z Yan American Journal of Physiology-Cell Physiology 287 (5), C1342-C1348, 2004 | 252 | 2004 |
| Neovascularization in atherectomy specimens from patients with unstable angina: implications for pathogenesis of unstable angina AN Tenaglia, KG Peters, MH Sketch Jr, BH Annex American heart journal 135 (1), 10-14, 1998 | 246 | 1998 |
| Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular … S Hazarika, AO Dokun, Y Li, AS Popel, CD Kontos, BH Annex Circulation research 101 (9), 948-956, 2007 | 240 | 2007 |
| Capillary density of skeletal muscle: a contributing mechanism for exercise intolerance in class II–III chronic heart failure independent of other peripheral alterations BD Duscha, WE Kraus, SJ Keteyian, MJ Sullivan, HJ Green, FH Schachat, ... Journal of the American College of Cardiology 33 (7), 1956-1963, 1999 | 239 | 1999 |
| The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching NC Kappas, G Zeng, JC Chappell, JB Kearney, S Hazarika, KG Kallianos, ... The Journal of cell biology 181 (5), 847-858, 2008 | 217 | 2008 |
